Lakefront Biotherapeutics (GLPGF) Cash & Equivalents (QoQ) (2014 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Cash & Equivalents (QoQ) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.28 Bn | 197.29 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.28 Bn | 178.10 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.58 Bn | 74.58 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.67 Bn | 56.48 Bn | 1.37 Bn |
| 6 | Moderna | 54.58 Bn | 49.44 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.70 Bn | 992.69 Mn |
| 8 | Biogen | 31.26 Bn | 29.98 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.78 Bn | 29.78 Bn | 1.16 Mn |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -23.53% |
| Dec 31, 2025 | 35.73% |
| Sep 30, 2025 | -7.11% |
| Jun 30, 2025 | -28.63% |
| Mar 31, 2025 | 65.60% |
| Dec 31, 2024 | 12.58% |
| Mar 31, 2024 | -55.59% |
| Dec 31, 2023 | 3.45% |
| Mar 31, 2023 | -74.30% |
| Mar 31, 2022 | -44.90% |
| Jun 30, 2020 | -13.29% |
| Mar 31, 2020 | 46.98% |
| Dec 31, 2019 | -66.93% |
| Sep 30, 2019 | 383.08% |
| Jun 30, 2019 | -7.20% |
| Mar 31, 2019 | -5.66% |
| Dec 31, 2018 | -5.73% |
| Sep 30, 2018 | 22.76% |
| Jun 30, 2018 | -6.49% |
| Mar 31, 2018 | 0.44% |